2m 2m 2m 2m 2m 2m 2m
Ocular Therapeut (OCUL)
NASDAQ
$6.70+$0.09 (+1.36%)
Price as of Nov 11, 2026 7:30 PM EST- $1.5BMarket Cap
- -41.09%1-Year Change
- BiotechnologyIndustry
Ocular Therapeut (OCUL)
$6.70+$0.09 (+1.36%)
Earnings Score
Valuation | OCUL | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -1 | ||
Growth | -1 | ||
Low Earnings Volatility | 2 |
Momentum Score
Valuation | OCUL | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | -18.18% | ||
12-Month Momentum | -30.19% | ||
3-Month Risk Adjusted Momentum | -58.35% | ||
12-Month Risk Adjusted Momentum | -41.49% |
True Yield
Valuation | OCUL | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | N/A | ||
Net Debt Paydown Yield | -0.03% |
Financial Health Score
Valuation | OCUL | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 3 |